Pembrolizumab in microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) and non–MSI-H/non–dMMR advanced endometrial cancer: Phase 2 KEYNOTE-158 study results
David M. O’Malley, Giovanni M. Bariani, Philippe A. Cassier, Aurélien Marabelle, Aaron R. Hansen, A. De Jesus Acosta, Wilson H. Miller, Tamar Safra, Antoîne Italiano, Linda Mileshkin, Lili Yao, Alexander Gozman, Fan Jin, Michele Maio
Topics & Concepts
Microsatellite instabilityDNA mismatch repairEndometrial cancerPembrolizumabMedicineCancer researchOncologyCancerInternal medicineGeneticsBiologyMicrosatelliteColorectal cancerGeneImmunotherapyAlleleEndometrial and Cervical Cancer TreatmentsGenetic factors in colorectal cancerGynecological conditions and treatments